Development of an animal model for neurocysticercosis: Immune response in the central nervous system is characterized by a predominance of γδ T cells

Journal of Immunology

Volumn 162, Issue 2, 1999, Pages 995-1002

  Cardona, Astrid E ^a   Restrepo, Blanca I ^a,b   Jaramillo, Juan M ^a,b   Teale, Judy M ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b Corp para Invest Biológicas ^*  (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE ACTIVATION; CYTOKINE PRODUCTION; FEMALE; HOST RESISTANCE; INFECTION RESISTANCE; INFLAMMATORY INFILTRATE; MACROPHAGE ACTIVATION; MESOCESTOIDEA; MOUSE; NATURAL KILLER CELL; NEUROCYSTICERCOSIS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANIMALS; BRAIN; CELL MOVEMENT; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; GENES, T-CELL RECEPTOR DELTA; GENES, T-CELL RECEPTOR GAMMA; LARVA; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE COUNT; MESOCESTOIDES; MICE; MICE, INBRED BALB C; NEUROCYSTICERCOSIS; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTE SUBSETS; TH1 CELLS;

EID: 0033555819     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Davis, L. E., and M. Kornfeld. 1991. Neurocysticercosis: neurologic, pathogenic, diagnostic and therapeutic aspects. Eur. Neurol. 31:229.
2. White, C. A., Jr. 1997. Neurocysticercosis: a major cause of neurological disease worldwide, Clin. Infect. Dis. 24:101.
3. Del Brutto, S. 1988. Neurocysticercosis: an update. Rev. Infect. Dis. 10:1075.
4. Schantz, P. M. 1989. Surveillance and control programs for cestodes diseases. In Parasitic Diseases: Treatment and Control. M. J. Miller and E. J. Love, eds. CRC Press. Boca Raton, FL, pp. 275-290.
5. Mahajan, R. C. 1982. Geographical distribution of human cysticercosis. In Cysticercosis: Present State of Knowledge and Perspectives. A. Flisser, K. Willims, and J. P. LaClette, editors. Academy Press, New York, pp. 39-46.
6. Tsang, V. C. W., and M. Wilson. 1995. Taenia solium cysticercosis: an under-recognized but serious public health problem. Parasitol. Today 11:124.
7. Schantz, P. M., A. C. Moore, J. L. Muñoz, B. J. Hartman, J. A. Schaefer, D. Persaud, E. Sarti, M. Wilson, and A. Flisser. 1992. Neurocysticercosis in an orthodox Jewish community in New York City. N. Engl. J. Med. 327:692.
8. Sorvillo, F. J., S. H. Waterman, F. O. Richards, and P. M. Schantz. 1992. Cysticercosis surveillance: locally acquired and travel-related infection and detection of intestinal tapeworm carriers in Los Angeles. Am. J. Trop. Med. Hyg. 47:365.
9. Stamos, J. K., E. G. Chadwick, P. M. Schantz, M. Wilson, and A. H. Rowley. 1994. New-onset seizures due to cysticercosis in low-risk children in Chicago. In Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Orlando, FL, p. 198.
10. Moore, A. C., L. I. Lutwick, P. M. Schantz, J. B. Pilcher, M. Wilson, A. W. Hightower, E. K. Chapnick, E. I. M. Abster, J. R. Grossman, J. A. Fried, D. A. Ware, X. Haichou, S. S. Hyon, R. L. Barbour, R. Antar, and A. Hakim. 1995. Seroprevalence of cysticercosis in an orthodox Jewish community. Am. J. Trop. Med. Hyg. 53:439.
11. Centers for Disease Control: locally acquired neurocysticercosis, North Carolina, Massachusetts and South Carolina, 1989-1991. 1992. Morbid. Mortal. Wkly. Rep. 41:1.
12. Pittella, J. E. 1997. Neurocysticercosis. Brain Pathol 7:681.
13. Escobar, A. 1983. The pathology of neurocysticercosis. In Cysticercosis of the Central Nervous System. E. Palacios, J. Rodriguez-Carbajal. and J. M. Taveras, eds. Thomas, Springfield, IL. 27-54.
14. Rabiela-Cervantes, M. T., A. Rivas-Hernandez, J. Rodriguez-Ibarra, S. Castillo-Medina, and F. M. Cancion. 1982. Anatomopathological aspects of human brain cysticercosis. In Cysticercosis: Present State of the Knowledge and Perspectives. A. Flisser, K. Willms, J. P. LaClette, C. Larralde, C. Ridaura, and F. Beltran, eds. Academic Press, New York, pp. 179-200.
15. Flisser, A., B. Espinoza, A. Tovar, A. Plancarte, and D. Correa. 1986. Hostparasite relationship in cysticercosis: immunologic study in different compartments of the host. Vet. Parasitol. 20:95.
16. Mitchell, G. F., J. J. Machalonis, P. M. Smith, W. L. Nicholas, and N. L. Warner. 1977. Studies on immune responses to larval cestodes in mice: immunoglobulins associated with the larvae of Mesocestoides corti. AJEBAK 55:187.
17. Eckert, J., T. Von Brand, and M. Voge. 1969. Asexual multiplication of Mesocestoides corti (Cestoda) in the intestine of dogs and skunks. J. Parasitol. 55:241.
18. Specht, D., and M. Voge. 1965. Asexual multiplication of Mesocestoides corti tetrathyridia in laboratory animals. J. Parasitol. 51:268.
19. Webster, J. 1948. Fragmentary studies on the life history of the cestode Mesocestiodes latus. J. Parasitol. 34:83.
20. Novak, M. 1972. Quantitative studies on the growth and multiplication of tetrathyridia of Mesocestoides corti Hoeppli. 1925 (Cestoda:Cyclophyllidia) in rodents. Can. J. Zool. 50:1189.
21. Restrepo, B. I., P. Llaguno, M. A. Sandoval, J. A. Enciso, and J. M. Teale. 1998. Analysis of immune lesions in neurocysticercosis: central nervous system response to helminth appears Th1-like instead of Th2. J. Neuroimmunol. 89:64.
22. Abraham, K. M., and J. M. Teale. 1987. The contribution of parasite-specific T cells to isotype restriction in Mesocestoides corti. J. Immunol. 139:2530.
23. Ding, J. C., M. Bauer, D. M. Diamond, M. A. Leal, D. Johnson, B. K. Williams, A. M. Thomas, L. Najvar, J. R. Graybill, and R. A. Larsen. 1997. Effect of severity of meningitis on fungicidal activity of flucytosine combined with fluconazole in a murine model for cryptoccocal meningitis. Antimicrob. Agents Chemother. 41:1589.
24. Neill, A. L., and N. H. Hunt. 1995. Effects of endotoxin and dexamethasone on cerebral malaria in mice. Parasitology 111:443.
25. Uyama, O., N. Okamura, M. Yanase, M. Narita, K. Kawabata, and M. Sugita. 1988. Quantitative evaluation of vascular permeability in the gerbil brain after transient ischemia using Evans blue fluorescence. J. Cereb. Blood Flow Metab. 8:282.
26. Wolman, M., I. Klatzo, E. Chui, F. Wilmes, K. Nishimoto, K. Fujiwara, and M. Spatz. 1981. Evaluation of the dye-protein tracers in pathophysiology of the blood-brain barrier. Acta Neuropathol. 54:55.
27. Garman, R. D., P. J. Doherty, and D. H. Raulet. 1986. Diversity, rearrangement and expression of murine T cell γ genes. Cell 45:733.
28. Fidel, P. L., N. A. Wolf, and M. KuKuruga. 1996. T lymphocytes in the murine vaginal mucosa are phenotypically distinct from those in the periphery. Infect. Immun. 64:3793.
29. Ito, A., and J. D. Smyth. 19987. Adult cestodes: immunology of the lumen dwelling cestode infections. In Immune Response in Parasitic Infections: Immunology. Immunopathology and Immunoprophylaxis. E. J. L. Soulsby. ed. CRC Press, Boca Raton, FL. pp 115-163.
30. Fan, P. C. 1988. Taiwan Taenia and taeniasis. Parasitol. Today 4:86
31. Fan, C., W. C. Chung, C. H. Chan, M. M. Wong, C. C. Wu, M. Hsu, S. H. Huang, and Y. A. Chen. 1987. Studies of taeniasis in Taiwan. III. Preliminary report of experimental infection of Taiwan Taenia in domestic animals. Proceedings of the First Sino-American Symposium on Biotechnology and Parasitic Diseases 1:119.
32. Kunz, J., B. Kalinna, V. Watscke, and E. Geyer. 1989. Taenia crassiceps. metacestode vesicular fluid antigens shared with the Taenia larval stage and reactive with serum antibodies from patients with neurocysticercosis. Zentralbl. Bakteriol. Mikrobiol. Hyg. Abt. 1 Orig. C271:510.
33. Larralde, C., R. M. Montoya, J. Sotelo, J. Hayunga, E. Scuitto, G. Palencia, A. Padilla, T. Govezensky, and M. L. Diaz. 1990. Murine T. crassiceps antigens in immunodiagnosis of T. solium human cysticercosis, T. saginata bovine cysticercosis, and human E. granulosus hydatidosis. Bull. Soc. Fr. Parasitol 8:58B.
34. Scuitto, E., G. Fragoso, M. Baca, V. de la Cruz, L. Lemus, and E. Lamoyi, 1995. Depressed T-cell proliferation associated with susceptibility to experimental infection with Taenia crassiceps infection. Infect. Immun. 63:2277.
35. Villa, O., and R. E. Kuhn. 1991. Antigenic and immunogenic analysis of Taenia crassiceps and Taenia solium using sera from their natural intermediate hosts. ASM Bull. 39:99.
36. Villa, O., and R. E. Kuhn. 1996. Mice infected with the larvae of Taenia crassiceps exhibit a Th2-like immune response with concomitant anergy and down-regulation of Th1-associated phenomena. Parasitology 112:561.
37. Hickey, W. F., B. L. Hsu, and H. Kimura. 1991. T-lymphocyte entry into the central nervous system. J. Neurosci. Res. 28:254.
38. Bradl, M. 1996. Immune control of the brain. Springer Semin. Immunopathol. 18:35.
39. Merril, J. E., and E. N. Benveniste. 1996. Cytokines in inflammatory brain lesions: helpful and harmful. Trends Neurosci. 19:331.
40. Shrinkant, P., and E. N. Benveniste. 1996. The central nervous system as an immunocompetent organ: role of glial cells in antigen presentation. J. Immunol. 157:1819.
41. White, C. A., Jr., P. Robinson, and R. Kuhn. 1997. Taenia solium cysticercosis: host-parasite interactions and the immune response. Chem. Immunol. 66:209.
42. Emani, F. P., and J. M. Teale. 1993. Release of stress proteins from Mesocestoides corti is a brefeldin A-inhibitable process: evidence for active export of stress proteins. Infect. Immun. 61:2596.
43. Estes, D. M., and J. M. Teale. 1991. Biochemical and functional analysis of extracellular stress proteins of Mesocestoides corti. J. Immunol. 147:3926.
44. Mosmann, T. R., and R. L. Coffman. 1989. Heterogeneity of cytokine secretion patterns and functions of helper T cells. Adv. Immunol. 46:111.
45. Sher, A., and R. L. Coffman. 1992. Regulation of immunity to parasites by T cells and T cell-derived cytokines. Annu. Rev. Immunol. 10:385.
46. Komatsu, T., and C. S. Reiss. 1997. IFN-γ is not required in the IL-12 response to vesicular stomatitis virus infection of the olfactory bulb. J. Immunol. 159:3444.
47. Cook, M. A., O. Cosme, D. Nedunchezian, and M. Stern. 1994. Neurocysticercosis: an old disease with new questions. J. Fam. Pract. 39:583.
48. Rajshekar, V., and M. Chandy. 1994. Enlarging solitary cysticercus granulomas. J. Neurosurg. 80:843.
49. Haas, W., P. Pereira, and S. Tonegawa. 1993. γ/δ Cells. Anna. Rev. Immunol. 11:637.
50. Carding, S. R., W. Allan, S. Kyes, A. Hayday, K. Bottomly, and P. C. Doherty. 1990. Late dominance of the inflammatory process in murine influenza by γδ+ T cells in vivo. J. Exp. Med. 172:1225.
51. Ohga, S., Y. Yoshikai, Y. Takeda, K. Hiromatse, and K. Nomoto. 1994. Sequential appearance of γδ and αβ bearing T cells in the peritoneal cavity during an intraperitoneal infection with Leisteria monocytogenes, J. Immunol. 20:533.
52. Ferrick, D., M. Schrenzel, T. Mulvania, B. Hsieh, W. Ferlin, and H. Lepper. 1995. Differential production of interferon-γ and interleukin-4 in response to Th1- and Th2-stimulatmg pathogens by γδ T cells in vivo. Nature 373:255.
53. Groh, V., A. Steinle, S. Bauer, and S, Thomas. 1998. Recognition of stress-induced MHC molecules by intestinal epithelial γδ T cells. Science 279:1737.
54. Kaufmann, S. H. E. 1997. The roles of conventional and unconventional T cells in antibacterial immunity. ASM News 63:251.
55. Li, H., M. I. Lebedeva, A. S. Llera, B. A. Fields, M. B. Brenner, and R. A. Mariuzza. 1998. Structure of the Vδ domain of the human γδ T-cell receptor. Nature 391:502.
56. Hvas, J., J. R. Oksenberg, R. Fernando, L. Steinman, and C. Bernard. 1993. γδ T cell receptor repertoire in brain lesions of patients with multiple sclerosis. J. Neuroimmunol. 46:225.
57. Christmas, S. 1992. Cytokine production by T lymphocytes bearing the γ-δ T cell antigen receptor. Chem. Immunol. 53:32.
58. Inagaki-Ohara, K., H. Nishimura, A. Mitani, and Y. Yoshikai. 1997. Interleukin-15 preferentially promotes the growth of intestinal intraepithelial lymphocytes bearing γ-δ T cell receptor in mice. Eur. J. Immunol. 27:2885.
59. Zambello, R., M. Facco, L. Trentin, R. Sancetta, C. Tassinari, A. Perin, A. Milani, G. Pizzolo, F. Rodeghiero, C. Agostini, R. Meazza, S. Ferrini, and G. Semenzato. 1997. Interleukin-15 triggers the proliferation and cytotoxicity of granular lymphocytes in patients with lymphoproliferative disease of granular lymphocytes. Blood 89-201.